Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

Clinical trial NCT00660660 · COMPLETED

Trial details

NCT number: NCT00660660
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2008-04-01
Primary completion: 2008-07-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.